Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Aptose Biosciences (GB:0UI8)
LSE:0UI8
Aptose Biosciences (0UI8) Stock Price & Analysis
0 Followers
0UI8 Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$3.05 - C$3.05
Previous CloseC$3.05
Volume0.00
Average Volume (3M)N/A
Market Cap
C$59.99M
Enterprise ValueC$6.64M
Total Cash (Recent Filing)$55.39M
Total Debt (Recent Filing)$271.00K
Price to Earnings (P/E)-5.2
Beta-0.08
Next Earnings
May 09, 2023EPS Estimate
-C$0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.59
Shares Outstanding92,367,275
10 Day Avg. Volume353
30 Day Avg. VolumeN/A
Standard Deviation0.25
R-Squared0.07
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)1.24
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-2.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.21
Forecast
1Y Price Target
C$10.46Price Target Upside243.11% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Aptose Biosciences News
0UI8 FAQ
What was Aptose Biosciences’s price range in the past 12 months?
Aptose Biosciences lowest stock price was C$3.05 and its highest was C$3.05 in the past 12 months.
What is Aptose Biosciences’s market cap?
Currently, no data Available
When is Aptose Biosciences’s upcoming earnings report date?
Aptose Biosciences’s upcoming earnings report date is May 09, 2023 which is in 42 days.
How were Aptose Biosciences’s earnings last quarter?
Aptose Biosciences released its earnings results on Mar 23, 2023. The company reported -C$0.15 earnings per share for the quarter, missing the consensus estimate of -C$0.147 by -C$0.003.
Is Aptose Biosciences overvalued?
According to Wall Street analysts Aptose Biosciences’s price is currently Undervalued.
Does Aptose Biosciences pay dividends?
Aptose Biosciences does not currently pay dividends.
What is Aptose Biosciences’s EPS estimate?
Aptose Biosciences’s EPS estimate is -C$0.16.
How many shares outstanding does Aptose Biosciences have?
Aptose Biosciences has 93,005,280 shares outstanding.
What happened to Aptose Biosciences’s price movement after its last earnings report?
Aptose Biosciences reported an EPS of -C$0.15 in its last earnings report, missing expectations of -C$0.147. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Aptose Biosciences?
Among the largest hedge funds holding Aptose Biosciences’s share is Carlson Capital LP. It holds Aptose Biosciences’s shares valued at 1M.
---
Aptose Biosciences Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$10.46 (243.11% Upside)
C$10.46 (243.11% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-46.16%
12-Months-Change
Fundamentals
Return on Equity
-74.70%
Trailing 12-Months
Asset Growth
-38.17%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Aptose Biosciences
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.
---
BriaCell Therapeutics
―
Portage Biotech Inc
―
Fusion Pharmaceuticals
―
Eupraxia Pharmaceuticals
―
---